Fundamental Analysis:
Ticker
MAIA
Current Price
$2.4 2.13%
Market Cap
$32.7M
Price Target
Refer to Report
Volume
28.9K
52wk Range
$2.12 - $9.64
Overview
MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, please visit www.maiabiotech.com.